Isolation and structural characterization of a molecular variant of dog pancreatic secretory trypsin inhibitor

J. Michael Gonion, Choong Bai Kim, Donal F. Magee

Research output: Contribution to journalArticlepeer-review

6 Citations (Scopus)

Abstract

A rapid two-step method has been developed for the purification of pancreatic secretory trypsin inhibitor (PSTI) from pancreatic juice obtained from dogs, stimulated with secretin and the octapeptide of cholecystokinin. The PSTI was isolated in two biologically active molecular forms. Determination of amino acid compositions and NH2-terminal amino acid sequences demonstrated that the major form represented the intact 57-amino-acid residue peptide, and the minor form (comprising 5-10% of the total activity) represented des[Asn1 Asn2 Met3] PSTL The metabolite arises from cleavage of a Met-Leu bond, and its formation may be a consequence of incomplete inhibition of chymotrypsinogen activation in the juice.

Original languageEnglish
Pages (from-to)59-64
Number of pages6
JournalInternational Journal of Pancreatology
Volume8
Issue number1
DOIs
Publication statusPublished (in print/issue) - Jan 1991

Keywords

  • cholecystokinin
  • HPLC
  • Kazal inhibitor
  • pancreatic juice, dog
  • Pancreatic secretory trypsin inhibitor
  • secretin

Fingerprint

Dive into the research topics of 'Isolation and structural characterization of a molecular variant of dog pancreatic secretory trypsin inhibitor'. Together they form a unique fingerprint.

Cite this